Participants at a recent FDA hearing said there is little data on whether smoking cessation drugs like Chantix and Zyban would be useful in treating teen electronic cigarette addictions.…
A new study appears to contradict previous findings indicating that Chantix and similar smoking cessation drugs carried an increased risk of heart problems.…
A new study warns that Chantix may increase the risk of heart problems, but carries low to no risk of neuropsychiatric side effects.…
The FDA has removed a black box warning on mental health side effects from Chantix and Zyban labels, saying an industry-run clinical trials show that the effects rarely result in serious injury.…
In a narrow vote, an FDA advisory panel has voted to recommend removing Chantix psychological side effects black box warnings from the smoking cessation drug, even though the FDA’s own reviewers and consumer watchdog groups raise questions about the validity of the new data provided by an industry-backed study.…
The FDA has ordered new alcohol side effects and seizure warnings added to the label of Chantix, and has refused to remove a black box warning on psychological side effects.…
A panel of FDA advisors has voted to keep a black box suidice warning on the smoking cessation drug Chantix.…
FDA reviewers say there is insufficient evidence to merit removing a warning from Chantix that alerts users to the risks of suicidal tendencies and violent urges.…
A group of nonprofits are calling for the FDA to strengthen label warnings on Chantix before a hearing next week.…
A new report warns that the smoking cessation drug Chantix is still the number one drug linked to thoughts of suicide and self-injurious behavior, suggesting that the FDA should not remove current black box warnings.…
